Harrigan Edmund
ACADIA Pharmaceuticals Inc. · Director
Harrigan Edmund is listed in public filings as director. This Harrigan Edmund insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include ACADIA Pharmaceuticals Inc. (ACAD), and Incyte Corp (INCY). Investors use Harrigan Edmund's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $347k16k shares | Grant / ExerciseMay 29, 2026 | $346.6K16k shares | $21.66 | -- | |
| --8.1k shares | Grant / ExerciseMay 29, 2026 | Disclosure amount unavailable8.1k shares | -- | -- | |
| --9.3k shares | Grant / ExerciseMay 29, 2026 | Disclosure amount unavailable9.3k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $2.0M21.1k shares | Grant / ExerciseMar 31, 2026 | $25.3K269 shares | $94.12 | -- | |
| $2.1M20.9k shares | Grant / ExerciseDec 31, 2025 | $24.2K245 shares | $98.77 | -- | |
| $1.7M20.6k shares | Grant / ExerciseSep 30, 2025 | $24.5K289 shares | $84.81 | -- | |
| $1.4M20.3k shares | Grant / ExerciseJun 30, 2025 | $25.0K367 shares | $68.10 | -- | |
| $646k9.2k shares | Grant / ExerciseJun 10, 2025 | $645.8K9.2k shares | $70.07 | -- | |
| --20k shares | Grant / ExerciseJun 10, 2025 | Disclosure amount unavailable2.5k shares | -- | -- | |
| $307k13.8k shares | Grant / ExerciseMay 29, 2025 | $307.4K13.8k shares | $22.29 | -- | |
| --9.4k shares | Grant / ExerciseMay 29, 2025 | Disclosure amount unavailable9.4k shares | -- | -- | |
| --8.1k shares | Grant / ExerciseMay 29, 2025 | Disclosure amount unavailable8.1k shares | -- | -- | |
| $1.1M17.4k shares | Grant / ExerciseMar 31, 2025 | $22.0K363 shares | $60.55 | -- |